S Rupert1, A Vassall2, N Raizada3, S D Khaparde4, C Boehme3, V S Salhotra5, K S Sachdeva4, S A Nair6, A H Van't Hoog7. 1. Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. 2. Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands, Social and Mathematical Epidemiology Group, Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK. 3. Foundation for Innovative New Diagnostics, New Delhi. 4. Central TB Division, Government of India, New Delhi. 5. Central TB Division, Ministry of Health and Family Welfare, New Delhi. 6. World Health Organization, Country Office for India, New Delhi, India. 7. Academic Medical Centre, University of Amsterdam, Department of Global Health, Amsterdam, The Netherlands.
Abstract
SETTING: Of 18 sites that participated in an implementation study of the Xpert® MTB/RIF assay in India, we selected five microscopy centres and two reference laboratories. OBJECTIVE: To obtain unit costs of diagnostic tests for tuberculosis (TB) and drug-resistant TB. DESIGN: Laboratories were purposely selected to capture regional variations and different laboratory types. Both bottom-up and the top-down methods were used to estimate unit costs. RESULTS: At the microscopy centres, mean bottom-up unit costs were respectively US$0.83 (range US$0.60-US$1.10) and US$12.29 (US$11.61-US$12.89) for sputum smear microscopy and Xpert. At the reference laboratories, mean unit costs were US$1.69 for the decontamination procedure, US$9.83 for a solid culture, US$11.06 for a liquid culture, US$29.88 for a drug susceptibility test, and US$18.18 for a line-probe assay. Top-down mean unit cost estimates were higher for all tests, and for sputum smear microscopy and Xpert these increased to respectively US$1.51 and US$13.58. The difference between bottom-up and top-down estimates was greatest for tests performed at the reference laboratories. CONCLUSION: These unit costs for TB diagnostics can be used to estimate resource requirements and cost-effectiveness in India, taking into account geographical location, laboratory type and capacity utilisation.
SETTING: Of 18 sites that participated in an implementation study of the Xpert® MTB/RIF assay in India, we selected five microscopy centres and two reference laboratories. OBJECTIVE: To obtain unit costs of diagnostic tests for tuberculosis (TB) and drug-resistant TB. DESIGN: Laboratories were purposely selected to capture regional variations and different laboratory types. Both bottom-up and the top-down methods were used to estimate unit costs. RESULTS: At the microscopy centres, mean bottom-up unit costs were respectively US$0.83 (range US$0.60-US$1.10) and US$12.29 (US$11.61-US$12.89) for sputum smear microscopy and Xpert. At the reference laboratories, mean unit costs were US$1.69 for the decontamination procedure, US$9.83 for a solid culture, US$11.06 for a liquid culture, US$29.88 for a drug susceptibility test, and US$18.18 for a line-probe assay. Top-down mean unit cost estimates were higher for all tests, and for sputum smear microscopy and Xpert these increased to respectively US$1.51 and US$13.58. The difference between bottom-up and top-down estimates was greatest for tests performed at the reference laboratories. CONCLUSION: These unit costs for TB diagnostics can be used to estimate resource requirements and cost-effectiveness in India, taking into account geographical location, laboratory type and capacity utilisation.
Authors: David J Lee; Nagalingeswaran Kumarasamy; Stephen C Resch; Gomathi N Sivaramakrishnan; Kenneth H Mayer; Srikanth Tripathy; A David Paltiel; Kenneth A Freedberg; Krishna P Reddy Journal: PLoS One Date: 2019-07-02 Impact factor: 3.240
Authors: Gabriela B Gomez; Richard G White; Chathika K Weerasuriya; Rebecca C Harris; C Finn McQuaid; Fiammetta Bozzani; Yunzhou Ruan; Renzhong Li; Tao Li; Kirankumar Rade; Raghuram Rao; Ann M Ginsberg Journal: BMC Med Date: 2021-02-26 Impact factor: 8.775
Authors: Grace Muzanyi; Y Mulumba; Paul Mubiri; Harriet Mayanja; John L Johnson; Ezekiel Mupere Journal: Afr Health Sci Date: 2019-06 Impact factor: 0.927
Authors: Nimalan Arinaminpathy; Gabriela B Gomez; Kuldeep S Sachdeva; Raghuram Rao; Malik Parmar; Sreenivas A Nair; Kiran Rade; Sameer Kumta; David Hermann; Christy Hanson; Daniel P Chin; Puneet Dewan Journal: PLoS One Date: 2020-03-27 Impact factor: 3.240
Authors: Valéria Martins Soares; Isabela Neves de Almeida; Maria Cláudia Vater; Suely Alves; Lida Jouca de Assis Figueredo; Luciene Scherer; Afrânio Lineu Kritski; Wânia da Silva Carvalho; Silvana Spindola de Miranda Journal: Rev Soc Bras Med Trop Date: 2020-02-07 Impact factor: 1.581